A randomized trial of pamrevlumab in patients with COVID-19 pneumonia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Respirology (Carlton, Vic.) - 28(2023), 10 vom: 21. Okt., Seite 954-957 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sgalla, Giacomo [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.09.2023 Date Revised 03.10.2023 published: Print-Electronic ClinicalTrials.gov: NCT05262309 Citation Status MEDLINE |
|---|
| doi: |
10.1111/resp.14575 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361036159 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361036159 | ||
| 003 | DE-627 | ||
| 005 | 20231226084308.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/resp.14575 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361036159 | ||
| 035 | |a (NLM)37605035 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sgalla, Giacomo |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A randomized trial of pamrevlumab in patients with COVID-19 pneumonia |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.09.2023 | ||
| 500 | |a Date Revised 03.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT05262309 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a interstitial lung disease | |
| 650 | 4 | |a lung fibrosis | |
| 650 | 4 | |a pulmonary fibrosis | |
| 650 | 7 | |a pamrevlumab |2 NLM | |
| 650 | 7 | |a QS5F6VTS0O |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 700 | 1 | |a Leone, Paolo Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Gualano, Gina |e verfasserin |4 aut | |
| 700 | 1 | |a Simonetti, Jacopo |e verfasserin |4 aut | |
| 700 | 1 | |a Comes, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Verdirosi, Diana |e verfasserin |4 aut | |
| 700 | 1 | |a Di Gennaro, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Larici, Anna Rita |e verfasserin |4 aut | |
| 700 | 1 | |a Ianniello, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Cicchetti, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Fusco, Nicoletta |e verfasserin |4 aut | |
| 700 | 1 | |a Pani, Marcello |e verfasserin |4 aut | |
| 700 | 1 | |a Palmieri, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Richeldi, Luca |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respirology (Carlton, Vic.) |d 1998 |g 28(2023), 10 vom: 21. Okt., Seite 954-957 |w (DE-627)NLM093444214 |x 1440-1843 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2023 |g number:10 |g day:21 |g month:10 |g pages:954-957 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/resp.14575 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2023 |e 10 |b 21 |c 10 |h 954-957 | ||